Mutations of other known drivers of CRC such as TP53, SMAD4, and PIK3CA are occasionally reported for CRC PM in literature (Lund‐Andersen et al, 2021), but low patient numbers make interpretation of these results difficult. Here, TP53 is linked to colorectal carcinoma.